-
PRME Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Prime Medicine (PRME)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm |
Cash burn (monthly) | (no burn) | (no burn) | 18.08 mm | 18.86 mm | 8.64 mm | 15.25 mm |
Cash used (since last report) | n/a | n/a | 74.14 mm | 77.34 mm | 35.43 mm | 62.54 mm |
Cash remaining | n/a | n/a | 57.89 mm | 54.69 mm | 96.61 mm | 69.50 mm |
Runway (months of cash) | n/a | n/a | 3.2 | 2.9 | 11.2 | 4.6 |
13F holders | Current |
---|---|
Total holders | 119 |
Opened positions | 15 |
Closed positions | 21 |
Increased positions | 38 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 240.15 bn |
Total shares | 116.43 mm |
Total puts | 64.40 k |
Total calls | 323.90 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
ARCH Venture Fund XII | 15.46 mm | $110.67 mm |
GOOG Alphabet | 15.06 mm | $58.29 bn |
GV 2019 | 15.06 mm | $120.95 mm |
ARCH Venture Fund X | 12.26 mm | $0.00 |
ARK Investment Management | 5.66 mm | $21.91 bn |
Newpath Partners | 5.31 mm | $0.00 |
BlackRock | 5.27 mm | $20.38 bn |
Vanguard | 4.89 mm | $18.93 bn |
T. Rowe Price Investment Management | 3.81 mm | $14.74 mm |
FMR | 3.74 mm | $14.49 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Dec 24 | Gottesdiener Keith Michael | Stock Option Common Stock | Grant | Acquire A | No | No | 8.32 | 100,000 | 832.00 k | 200,000 |
5 Dec 24 | Richard Brudnick | Stock Option Common Stock | Grant | Acquire A | No | No | 7.96 | 19,300 | 153.63 k | 57,900 |
5 Dec 24 | Allan Reine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 75,000 | 510.00 k | 775,000 |
8 Oct 24 | Gottesdiener Keith Michael | Common Stock | Gift | Acquire G | Yes | No | 0 | 226,925 | 0.00 | 682,259 |
8 Oct 24 | Gottesdiener Keith Michael | Common Stock | Gift | Dispose G | Yes | No | 0 | 226,925 | 0.00 | 50,241 |
12 Jun 24 | Schenkein David P | Stock Option Common Stock | Grant | Acquire A | No | No | 7.68 | 45,000 | 345.60 k | 45,000 |